Akcea Therapeutics, Inc. Defined Contribution Plan, Cost
Akcea Therapeutics, Inc. reported Defined Contribution Plan, Cost of $2.10 million for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-02.
Discontinued › Expense Statement › Operating Expenses
us-gaap:DefinedContributionPlanCostRecognized · last filed 2020-03-02
- Akcea Therapeutics, Inc. defined contribution plan, cost for fiscal 2019 was $2.10M, a 31.25% increase from fiscal 2018.
- Akcea Therapeutics, Inc. defined contribution plan, cost for fiscal 2018 was $1.60M, a 433.33% increase from fiscal 2017.
- Akcea Therapeutics, Inc. defined contribution plan, cost for fiscal 2017 was $300.00K, a 50.00% increase from fiscal 2016.
- Akcea Therapeutics, Inc. defined contribution plan, cost for fiscal 2016 was $200.00K.
| Period end | Defined Contribution Plan, Cost 12 month | Defined Contribution Plan, Cost 12 month as first filed |
|---|---|---|
| 2019-12-31 | $2.10M 10-K · filed 2020-03-02 | |
| 2018-12-31 | $1.60M 10-K · filed 2020-03-02 | |
| 2017-12-31 | $300.00K 10-K · filed 2020-03-02 | $299.00K 10-K · filed 2018-02-28 |
| 2016-12-31 | $200.00K 10-K · filed 2019-03-01 | $211.00K 10-K · filed 2018-02-28 |
| 2015-12-31 | $28.00K 8-K · filed 2018-09-18 |